metopimazine has been researched along with Breast Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boesgaard, M; Dombernowsky, P; Herrstedt, J; Jensen, TP; Sigsgaard, T | 1 |
Andersen, LJ; Dombernowsky, P; Havsteen, H; Herrstedt, J; Kjaer, M; Kjaerbøl, AG; Langer, SW; Lund, H; Sigsgaard, T | 1 |
Andersen, O; Christensen, P; Dombernowsky, P; Herrstedt, J; Sigsgaard, T | 1 |
Dombernowsky, P; Handberg, J; Herrstedt, J; Kjaer, M; Sigsgaard, T | 1 |
4 trial(s) available for metopimazine and Breast Neoplasms
Article | Year |
---|---|
Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Isonipecotic Acids; Male; Middle Aged; Nausea; Ondansetron; Vomiting | 1993 |
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Methotrexate; Middle Aged; Nausea; Prednisolone; Serotonin Antagonists; Vomiting | 1999 |
Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Female; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Middle Aged; Nausea; Prednisolone; Treatment Outcome; Vomiting | 2000 |
Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isonipecotic Acids; Logistic Models; Middle Aged; Nausea; Ondansetron; Prednisolone; Statistics, Nonparametric; Vomiting | 2001 |